SCIELE PHARMA, INC. 4
4 · SCIELE PHARMA, INC. · Filed May 19, 2008
Insider Transaction Report
Form 4
FOURTEAU PATRICK
CEO and President
Transactions
- Exercise/Conversion
Common
2008-05-15+100,000→ 598,533 total - Sale
Common
2008-05-15$21.08/sh−100,000$2,107,610→ 498,533 total - Exercise/Conversion
Common Stock Options
2008-05-15−50,000→ 325,000 totalExercise: $11.46From: 2004-12-22Exp: 2010-12-22→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Acquired on exercise of stock options reported in Table II of this Form 4
- [F2]Price paid on acquisition equals exercise price of shares underlying stock options reported in Table II of this Form 4
- [F3]Sold pursuant to Mr. Fourteau's 10b5-1 sales plan